1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
US Proton Therapy Market Opportunity Analysis

US Proton Therapy Market Opportunity Analysis

  • December 2014
  • 87 pages
  • ID: 4397239
  • Format: PDF
  • By Kuick Research

Summary

Table of Contents

Proton beam therapy is seen as the next great leap forward in treating cancer with radiation. It has been found that proton therapy is beneficial for tumors surrounded by sensitive structures such as the eye, brain, and spinal cord, where the organs are sensitive and there is high potential for radiation damage. Proton therapy is also very useful in childhood cancer treatment due to the high risk of long-term side effects in children during standard radiation treatment. The major advantage is that there is minimal or no side effects compared to conventional forms of radiation which makes this therapy much more easily tolerated than standard radiation therapy.

Proton therapy is applied to a specific area of the patient's body which means that this therapy can be used to shrink tumors that have not spread to other parts of the body. Tumors adjoining sensitive and critically important tissues such as the optic nerves that travel between the eye and brain need protection from radiation damage and such cases are best treated with proton therapy. Doctors now use proton therapy exclusively or in conjunction with standard radiation therapy, surgery, and/or chemotherapy. In children that are infected with cancer, proton therapy is particularly useful for treatment because it reduces the chance of harming healthy, developing tissue. Proton therapy can also be used in children for rare cancers of the central nervous system (brain and spinal cord) and the eye, such as retinoblastoma and orbital rhabdomyosarcoma.

In US, there are about 14 proton therapy centers catering to a potential patient base of more than 350,000 cancer patients with respect to treatment with proton therapy. This number is expected to cross 24 by 2020. This number of centers, though not sizable, still points to a huge multi Billion dollar potential market for the companies, though there would still be a majority of cancer patients who can likely benefit with proton therapy, but who may have fallen off the map.

The market for proton therapy centers and the demand for these facilities are growing driven by the number of cancer diagnoses. Of this prostate cancer that has about 186,320 patient additions a year has seen a favorable impression of the therapy. There are also other positive aspects in this scenario such as that of the Loma Linda facility which has been using protons to treat men with prostate cancer since 1991 and found that major rectal and urinary side effects occur among less than 1% of its patients. The absence of such risks associated with other radiation treatments or surgery is a major driving factor driving the demand for proton therapy among patients.

In the US the way forward for proton therapy is expected to be in establishing a nationwide network of proton facilities, given that so many cancer patients lack access to the technology. In doing this the role of the corporate and private medical sector would be equal or more than the academic proton centers which their own issues to grapple with. Another area of development that will promote growth in this sector is that of proton beam technology itself which is rapidly advancing. We can expect to see American centers upgrading to intensity modulated proton beam therapy that will make it more accurate.



“US Proton Therapy Market Opportunity Analysis” Report Highlight:

US Proton Therapy Market Overview
Targeted Patient Base & Economic Capacity Analysis
Proton Therapy Cost Analysis
Proton Therapy Reimbursement Policy
Proton Therapy Center Infrastructure Analysis
US Proton Therapy Market Dynamics
Insight on Operating & Upcoming Proton Therapy Centers

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
High Affinity Nerve Growth Factor Receptor - Pipeline Review, H1 2020

High Affinity Nerve Growth Factor Receptor - Pipeline Review, H1 2020

  • $ 3500
  • January 2020

High Affinity Nerve Growth Factor Receptor - Pipeline Review, H1 2020SummaryHigh Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase ...

Transforming Growth Factor Beta 2 - Pipeline Review, H2 2019

Transforming Growth Factor Beta 2 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019

Transforming Growth Factor Beta 2 - Pipeline Review, H2 2019SummaryAccording to the recently published report ’Transforming Growth Factor Beta 2 - Pipeline Review, H2 2019’; Transforming Growth Facto ...

Poly [ADP Ribose] Polymerase 2 - Pipeline Review, H2 2019

Poly [ADP Ribose] Polymerase 2 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019

Poly [ADP Ribose] Polymerase 2 - Pipeline Review, H2 2019SummaryPoly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose] Synthase ...


ref:plp2014

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on